Eric Jablon
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Traumatic Ocular and Foreign Body Injuries
- Glaucoma and retinal disorders
- Retinal and Optic Conditions
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
Papers in
-
- Retinal Diseases and Treatments 4
- Retinal and Optic Conditions 2
- Ocular Diseases and Behçet’s Syndrome 1
-
- Retinopathy of Prematurity Studies 1
- Retinal Imaging and Analysis 1
- Co-authors
- D. Virgil Alfaro (5 shared papers)John Kerrison (4 shared papers)Michael D. Grossman (1 shared paper)Robert A. Morris (1 shared paper)Virgil Alfaro (2 shared papers)Hugo Quiroz–Mercado (1 shared paper)Nauman Chaudhry (1 shared paper)Peter E. Liggett (1 shared paper)
- Journals
- Current Diabetes Reviews (3 papers)American Journal of Ophthalmology (1 paper)Investigative Ophthalmology & Visual Science (1 paper)Ophthalmic surgery, lasers & imaging retina (1 paper)Retinal Cases & Brief Reports (1 paper)
- Partner nations
- United StatesHungary
In The Last Decade
Eric Jablon
8 papers receiving 403 citations
Peers
Comparison fields: 5 of 60
- Ophthalmology 207
- Clinical Biochemistry 34
- Radiology, Nuclear Medicine and Imaging 92
- Cancer Research 34
- Molecular Biology 105
Countries citing papers authored by Eric Jablon
This map shows the geographic impact of Eric Jablon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Jablon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Jablon more than expected).
Fields of papers citing papers by Eric Jablon
This network shows the impact of papers produced by Eric Jablon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Jablon. The network helps show where Eric Jablon may publish in the future.
Co-authors
The 9 scholars most cited alongside Eric Jablon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 268 | |
| 2 | 2009 | 54 | |
| 3 | 2005 | 52 | |
| 4 | 2009 | 24 | |
| 5 | 2005 | 17 | |
| 6 | 2005 | 9 | |
| 7 | 2008 | 1 | |
| 8 | Ranibizumab for the Treatment of Branch Retinal Vein Occlusion-Associated Cystoid Macular Edema | 2008 | 1 |
About Eric Jablon
Eric Jablon is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Genetics, Molecular Biology and Endocrinology, Diabetes and Metabolism, having authored 8 papers that have together received 426 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (4 papers), Retinal and Optic Conditions (2 papers), Diabetes Management and Research (1 paper), Ocular Diseases and Behçet’s Syndrome (1 paper), Retinopathy of Prematurity Studies (1 paper), Diabetes and associated disorders (1 paper), Retinal Imaging and Analysis (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Ophthalmology (207 citations), Clinical Biochemistry (34 citations), Radiology, Nuclear Medicine and Imaging (92 citations), Cancer Research (34 citations) and Molecular Biology (105 citations). Eric Jablon has collaborated with scholars based in United States and Hungary. Frequent co-authors include D. Virgil Alfaro, John Kerrison, Michael D. Grossman, Robert A. Morris, Virgil Alfaro, Hugo Quiroz–Mercado, Nauman Chaudhry, Peter E. Liggett and Francisco Gómez‐Ulla. Their work appears in journals such as Current Diabetes Reviews, American Journal of Ophthalmology, Investigative Ophthalmology & Visual Science, Ophthalmic surgery, lasers & imaging retina and Retinal Cases & Brief Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.